Agile Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment ConferenceGlobeNewsWire • 09/06/22
These Are The Five Best And Worst Performing Penny Stocks Of 2022 (So Far)24/7 Wall Street • 09/03/22
Agile Therapeutics, Inc. (AGRX) CEO Al Altomari on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/11/22
Agile Therapeutics to Report Second Quarter 2022 Financial Results and Provide Business Update on Thursday, August 11, 2022GlobeNewsWire • 07/28/22
Agile Therapeutics to Participate in Maxim Group's Upcoming Women's Health PanelGlobeNewsWire • 07/08/22
Agile Therapeutics to Present at The H.C. Wainwright Global Investment ConferenceGlobeNewsWire • 05/17/22
Agile Therapeutics, Inc. (AGRX) CEO Al Altomari on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/13/22
Agile Therapeutics Announces Findings of First-Year Post-Marketing Pharmacovigilance in ACOG Poster PresentationGlobeNewsWire • 05/05/22
Agile Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on Thursday, May 12, 2022GlobeNewsWire • 05/03/22
Agile Therapeutics Announces First Quarter 2022 Prescription Data for Twirla®GlobeNewsWire • 04/14/22
Agile Therapeutics Receives $4.7M After Selling Net Operating Loss Tax Benefits Through New Jersey Economic Development ProgramGlobeNewsWire • 04/11/22